Ignite Creation Date:
2025-12-25 @ 4:29 AM
Ignite Modification Date:
2026-03-01 @ 6:10 AM
Study NCT ID:
NCT02839720
Status:
COMPLETED
Last Update Posted:
2023-12-06
First Post:
2016-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-20
First Submit QC Date:
None
Study First Post Date:
2016-07-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-09-22
Results First Submit QC Date:
None
Results First Post Date:
2023-12-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-05
Last Update Post Date:
2023-12-06
Last Update Post Date Type:
ACTUAL